PATENT CLAIM ANALYSIS

Application Number: 15765559
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["424", "001110"]

Abstract:
A colloidal suspension of hyaluronic acid and Sn-117m is used to treat joint inflammation. In one embodiment, Sn-117m is bonded to hyaluronic acid. Alternately, the Sn-117m can be dissolved in the hyaluronic acid colloidal suspension. This is injected into an inflamed joint, providing short-term and long-term relief.

Claim (Index 7):
A method of treating a disorder selected from the group consisting of rheumatoid arthritis, spondyloarthropathy, psoriatic arthritis, ankylosing spondylitis, reactive arthritis, enteropathic arthritis, other inflammatory joint diseases such as Beh\u00e7et and lyme disease, calcium pyrophosphate deposition arthritis, pigmented villo-nodular synovitis, hemophilic arthropathy, osteoarthritis, recurrent joint effusion after surgery or prosthesis, other undifferentiated arthritis such as recurrent synovitis, recurrent hydrarthrosis and synovial thickening comprising administering a dose of the composition of  claim 1  into the affected joint in an amount effective to treat the disorder.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.54286
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14367758', '15264550', '13387682', '14452836', '14929115']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6757235539051096
- 35 USC 102 Novelty (BERT): 0.4805688331383372
- Combined Prediction Score: 0.6562080818284324
- Mean Citation Score: 115.508674
- Max Citation Score: 139.92623999999998
- Similarity Product: 92.10392512035368

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test